Regeneron Announces Upcoming Investor Conference Presentations

TARRYTOWN, N.Y., May 18, 2017 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. REGN will webcast management presentations as follows:

• Bernstein 33^rd Annual Strategic Decisions Conference at 5:00 p.m. ET on Wednesday, May 31, 2017
• Goldman Sachs 38^th Annual Global Healthcare Conference at 8:40 a.m. PT (11:40 a.m. Eastern Time) on Tuesday, June 13, 2017

The sessions may be accessed through the Company's web site, www.regeneron.com, on the 'Events and Presentations' page.  Archived versions of the presentations will be available for 30 days.

About Regeneron Pharmaceuticals, Inc.
Regeneron REGN is a leading science-based biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions. Regeneron commercializes medicines for eye diseases, high LDL cholesterol, atopic dermatitis and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including rheumatoid arthritis, asthma, pain, cancer and infectious diseases. For additional information about the company, please visit www.regeneron.com or follow @Regeneron on Twitter.

Contact Information:                       

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/regeneron-announces-upcoming-investor-conference-presentations-300459452.html

SOURCE Regeneron Pharmaceuticals, Inc.